Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Therapy Resistant LUTS (OptiLUTS) Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation: a Prospective Single Centre Study.

NCT05313984 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05313984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Therapy Resistant LUTS (OptiLUTS) Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation: a Prospective Single Centre Study.
Lead sponsor
University Hospital, Ghent
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
December 31, 2021
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysfunctional voiding, fecal incontinence, fowler syndrome, overactive bladder syndrome, urinary retention